Carlo Salvarani

7.4k total citations
82 papers, 1.3k citations indexed

About

Carlo Salvarani is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Carlo Salvarani has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 43 papers in Rheumatology and 21 papers in Genetics. Recurrent topics in Carlo Salvarani's work include Vasculitis and related conditions (42 papers), Otitis Media and Relapsing Polychondritis (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers). Carlo Salvarani is often cited by papers focused on Vasculitis and related conditions (42 papers), Otitis Media and Relapsing Polychondritis (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (16 papers). Carlo Salvarani collaborates with scholars based in Italy, United States and United Kingdom. Carlo Salvarani's co-authors include Francesco Muratore, Giulia Cassone, Marco Sebastiani, Andreina Manfredi, Caterina Vacchi, Gene G. Hunder, Sherine E. Gabriel, Nicolò Pipitone, María C. Cid and Wolfgang Schmidt and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carlo Salvarani

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Salvarani Italy 23 837 719 285 236 176 82 1.3k
Hubert de Boysson France 25 1.3k 1.5× 966 1.3× 401 1.4× 282 1.2× 244 1.4× 103 1.8k
Kornelis S. M. van der Geest Netherlands 25 1.3k 1.5× 894 1.2× 399 1.4× 233 1.0× 540 3.1× 94 1.9k
Bernhard Nölle Germany 14 1.1k 1.3× 578 0.8× 256 0.9× 560 2.4× 109 0.6× 34 1.5k
Konstanze Holl‐Ulrich Germany 19 1.2k 1.4× 655 0.9× 192 0.7× 460 1.9× 375 2.1× 67 1.5k
P.Y. Hatron France 18 563 0.7× 588 0.8× 170 0.6× 209 0.9× 170 1.0× 84 1.5k
Louise Galmiche France 23 558 0.7× 260 0.4× 87 0.3× 101 0.4× 94 0.5× 89 1.7k
Park Yb South Korea 16 305 0.4× 327 0.5× 69 0.2× 70 0.3× 203 1.2× 32 903
Ruth Ann Vleugels United States 22 202 0.2× 670 0.9× 83 0.3× 91 0.4× 307 1.7× 117 1.6k
Ronald G. Swee United States 20 1.0k 1.2× 1.6k 2.2× 53 0.2× 132 0.6× 484 2.8× 25 2.1k
D. Boumpas Greece 9 137 0.2× 514 0.7× 163 0.6× 50 0.2× 246 1.4× 17 871

Countries citing papers authored by Carlo Salvarani

Since Specialization
Citations

This map shows the geographic impact of Carlo Salvarani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Salvarani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Salvarani more than expected).

Fields of papers citing papers by Carlo Salvarani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Salvarani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Salvarani. The network helps show where Carlo Salvarani may publish in the future.

Co-authorship network of co-authors of Carlo Salvarani

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Salvarani. A scholar is included among the top collaborators of Carlo Salvarani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Salvarani. Carlo Salvarani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marvisi, Chiara, et al.. (2025). Diagnostic approach in giant cell arteritis. Autoimmunity Reviews. 24(4). 103743–103743. 1 indexed citations
2.
Samson, Maxime, Bhaskar Dasgupta, Anthony M. Sammel, et al.. (2024). Targeting interleukin-6 pathways in giant cell arteritis management: A narrative review of evidence. Autoimmunity Reviews. 24(2). 103716–103716. 3 indexed citations
3.
Pesce, Elisa, Mauro Bombaci, Stefania Croci, et al.. (2024). Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis. Clinical and Experimental Rheumatology. 42(7). 1317–1320. 1 indexed citations
4.
Cantini, Fabrizio, Antonio Marchesoni, Lucia Novelli, et al.. (2024). Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials. Lara D. Veeken. 63(11). 3146–3154. 2 indexed citations
5.
Muratore, Francesco, Chiara Marvisi, Giulia Cassone, et al.. (2024). Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study. Lara D. Veeken. 64(5). 3057–3062. 3 indexed citations
6.
Alba, Marco A., Sebastian Unizony, Kenneth J. Warrington, et al.. (2024). Management of Relapses in Giant Cell Arteritis. Arthritis & Rheumatology. 77(6). 632–645.
7.
Marvisi, Chiara, Ertuğrul Çağrı Bölek, Mark A. Ahlman, et al.. (2023). Development of the Takayasu Arteritis Integrated Disease Activity Index. Arthritis Care & Research. 76(4). 531–540. 10 indexed citations
8.
Carletto, Antonio, Alen Zabotti, Roberta Ramonda, et al.. (2023). Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study. Arthritis Research & Therapy. 25(1). 196–196. 1 indexed citations
9.
Berti, Alvise, Fabiola Atzeni, Lorenzo Dagna, et al.. (2022). Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities. Annals of the Rheumatic Diseases. 82(2). 164–168. 13 indexed citations
10.
Ughi, Nicola, Roberto Padoan, Chiara Crotti, et al.. (2022). The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis. SHILAP Revista de lepidopterología. 73(4). 7 indexed citations
11.
Cassone, Giulia, Giovanni Dolci, Giulia Besutti, et al.. (2022). Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis. PLoS ONE. 17(1). e0262908–e0262908. 2 indexed citations
12.
Besutti, Giulia, Massimo Pellegrini, Marta Ottone, et al.. (2022). Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study. Nutrients. 14(18). 3764–3764. 3 indexed citations
13.
Salvarani, Carlo, Marco Sebastiani, Philippe Dieudé, et al.. (2021). Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials. Rheumatology and Therapy. 8(3). 1435–1441. 20 indexed citations
14.
Marchesoni, Antonio, Pierluigi Macchioni, Stefania Gasparini, et al.. (2021). Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study. Journal of Clinical Medicine. 11(1). 180–180. 8 indexed citations
15.
Besutti, Giulia, Massimo Pellegrini, Marta Ottone, et al.. (2021). The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS ONE. 16(5). e0251768–e0251768. 28 indexed citations
16.
Vacchi, Caterina, Andreina Manfredi, Giulia Cassone, et al.. (2020). Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease. SHILAP Revista de lepidopterología. 2020. 1–4. 11 indexed citations
17.
Vacchi, Caterina, Marco Sebastiani, Giulia Cassone, et al.. (2020). Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review. Journal of Clinical Medicine. 9(2). 407–407. 47 indexed citations
18.
Monti, Sara, Ana Águeda, Raashid Luqmani, et al.. (2019). Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis. RMD Open. 5(2). e001003–e001003. 47 indexed citations
19.
Ehlers, Lisa, Johan Askling, Maurizio Cutolo, et al.. (2019). 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Annals of the Rheumatic Diseases. 78(9). 1160–1166. 57 indexed citations
20.
Manfredi, Andreina, Marco Sebastiani, Stefania Cerri, et al.. (2019). Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature. Journal of Thoracic Disease. 11(4). 1621–1628. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert de Boysson Breakdown of academic impact, for papers by Kornelis S. M. van der Geest Breakdown of academic impact, for papers by Bernhard Nölle Breakdown of academic impact, for papers by Konstanze Holl‐Ulrich Breakdown of academic impact, for papers by P.Y. Hatron Breakdown of academic impact, for papers by Louise Galmiche Breakdown of academic impact, for papers by Park Yb Breakdown of academic impact, for papers by Ruth Ann Vleugels Breakdown of academic impact, for papers by Ronald G. Swee Breakdown of academic impact, for papers by D. Boumpas
Rankless by CCL
2026